HTA89 ANDROGEN RECEPTOR INHIBITORS FOR THE TREATMENT OF NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Santos, A. [1 ]
Carvalho, L. [2 ]
Kelles, S. [3 ]
机构：
[1] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil
[3] Unimed BH, Belo Horizonte, MG, Brazil
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA89
引用
收藏
页码：S313 / S313
页数：1
相关论文
共 50 条
  • [1] Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
    Lavaud, Pernelle
    Dumont, Clement
    Thibault, Constance
    Albiges, Laurence
    Baciarello, Giulia
    Colomba, Emeline
    Flippot, Ronan
    Fuerea, Alina
    Loriot, Yohann
    Fizazi, Karim
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [2] Prognostic factors for non-metastatic castration-resistant prostate cancer treated with androgen receptor signaling inhibitors
    Takahara, Kiyoshi
    Naiki, Taku
    Nakane, Keita
    Watanabe, Hiromitsu
    Miyake, Hideaki
    Koie, Takuya
    Yasui, Takahiro
    Shiroki, Ryoichi
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 21 (04)
  • [3] Novel Treatment Strategy Using Second-Generation Androgen Receptor Inhibitors for Non-Metastatic Castration-Resistant Prostate Cancer
    Chung, Doo Yong
    Ha, Jee Soo
    Cho, Kang Su
    BIOMEDICINES, 2021, 9 (06)
  • [4] Apalutamide for the Treatment of non-metastatic castration-resistant Prostate Cancer
    Miller, Kurt
    ONKOLOGE, 2019, 25 (03): : 275 - 276
  • [5] Treatment and trials in non-metastatic castration-resistant prostate cancer
    Soum D. Lokeshwar
    Zachary Klaassen
    Fred Saad
    Nature Reviews Urology, 2021, 18 : 433 - 442
  • [6] Treatment and trials in non-metastatic castration-resistant prostate cancer
    Lokeshwar, Soum D.
    Klaassen, Zachary
    Saad, Fred
    NATURE REVIEWS UROLOGY, 2021, 18 (07) : 433 - 442
  • [7] A new androgen receptor antagonist Darolutamide for patients with non-metastatic castration-resistant prostate cancer
    Kesch, C.
    Hadaschik, B. A.
    UROLOGE, 2019, 58 (10): : 1217 - 1218
  • [8] Darolutamide for non-metastatic, castration-resistant prostate cancer
    Burki, Talha
    LANCET ONCOLOGY, 2019, 20 (03): : E139 - E139
  • [9] Physician preferences for non-metastatic castration-resistant prostate cancer treatment
    Srinivas, Sandy
    Mohamed, Ateesha F.
    Appukkuttan, Sreevalsa
    Botteman, Marc
    Ng, Xinyi
    Joshi, Namita
    Horodniceanu, Erica
    Waldeck, A. Reginald
    Simmons, Stacey J.
    BMC UROLOGY, 2020, 20 (01)
  • [10] The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer
    El-Amm, Joelle
    Aragon-Ching, Jeanny B.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2019, 13
12345